About Cathy Wintsch

This author has not yet filled in any details.
So far Cathy Wintsch has created 64 blog entries.

Support by the CANSEARCH Foundation, of Dr. Nicolas Waespe

The CANSEARCH Foundation is pleased to fund Dr. Nicolas Waespe, a hematologist-pediatric oncologist and associate at the Institute of Social and Preventive Medicine in Berne, where the Swiss Childhood Cancer Registry is located.

The collaboration concerns two projects: the project “BioLink, a contribution to the networking of biobanks for research purposes” to link the Swiss Childhood Cancer Registry in Berne, the BaHOP in Geneva (“Biobank for Hematology and Oncology in Pediatrics “) and the tumor tissue bank based in Zurich, to provide researchers with clinical and genetic data on children who have been diagnosed with cancer or who will be diagnosed in the future.

The second project is a study on the long-term toxicity of some children who have been diagnosed with cancer. This study called GECCOS (“Genetic risks for Complications in Children after Oncological Treatment in Switzerland”), which is related to our biobank […]

2019-05-12T17:20:11+00:00May 12th, 2019|News|0 Comments

European Society of Pharmacogenomics and Personalised Therapy – Summer School

CANSEARCH co organised, from 25 – 27 September, a Summer School with the European Society of Pharmacogenomics and Personalized Therapy (ESPT) and the Swiss Personalized Health Network (SPHN) at the Geneva Biotech Campus on Personalized Medicine. More than 30 experts presented the latest developments in this innovative field.   http://www.esptsummerschool.eu

 

2018-10-29T16:06:45+00:00October 29th, 2018|News|0 Comments

American Hematology Society (ASH)

We are pleased to announce the participation of Professor Ansari and his researchers at the 59th ASH Congress to be held from 9-12 December 2017 in Atlanta. Presentations will focus on:

  1. Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? ­ a Multicenter EBMT-PDWP Study.
  2. Outcome of Children Relapsing after First Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia: A Retrospective I-BFM Analysis of 336 Children between 2005 and 2016.
  3. A Protective Role of DNA Repair Genes Against Acute Graft Versus Host Disease in Children. 
2017-11-21T08:19:23+00:00November 20th, 2017|News|0 Comments
Go to Top